UBS estimated a negative impact of $13 billion from fair value adjustments of the combined group’s financial assets and liabilities, and a further $4 billion in potential litigation and regulatory costs stemming from outflows
The considerations are at an early stage as UBS is focused on completing that takeover and it may not make a final decision on whether to pursue an IPO for months, a source claimed